Baillie Gifford & Co
BNR

Baillie Gifford & Co’s Burning Rock Biotech BNR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-156,912
Closed -$152K 292
2023
Q3
$152K Sell
156,912
-3,269
-2% -$3.17K ﹤0.01% 281
2023
Q2
$349K Hold
160,181
﹤0.01% 281
2023
Q1
$450K Hold
160,181
﹤0.01% 278
2022
Q4
$360K Hold
160,181
﹤0.01% 288
2022
Q3
$383K Sell
160,181
-177,712
-53% -$425K ﹤0.01% 286
2022
Q2
$983K Sell
337,893
-8,573,357
-96% -$24.9M ﹤0.01% 275
2022
Q1
$82.8M Buy
8,911,250
+10,747
+0.1% +$99.8K 0.06% 150
2021
Q4
$84.8M Buy
8,900,503
+108,351
+1% +$1.03M 0.05% 152
2021
Q3
$157M Buy
8,792,152
+329,730
+4% +$5.9M 0.08% 126
2021
Q2
$249M Buy
8,462,422
+1,880,294
+29% +$55.4M 0.12% 117
2021
Q1
$177M Buy
6,582,128
+5,004,571
+317% +$135M 0.1% 127
2020
Q4
$36.4M Buy
1,577,557
+565,285
+56% +$13.1M 0.02% 178
2020
Q3
$25.4M Buy
1,012,272
+293,672
+41% +$7.37M 0.02% 175
2020
Q2
$19.4M Buy
+718,600
New +$19.4M 0.01% 170